The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies

AT Amare, KO Schubert, M Klingler-Hoffmann… - Translational …, 2017 - nature.com
Meta-analyses of genome-wide association studies (meta-GWASs) and candidate gene
studies have identified genetic variants associated with cardiovascular diseases, metabolic …

Elevated clozapine levels associated with infection: a systematic review

…, NS Warren, G Kim, D Jankowiak, KO Schubert… - Schizophrenia …, 2018 - Elsevier
Clozapine is the most effective anti-psychotic medication for treatment refractory schizophrenia.
A growing number of case reports have linked infection to high clozapine levels and …

Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide …

AT Amare, KO Schubert, L Hou, SR Clark… - JAMA …, 2018 - jamanetwork.com
Importance Lithium is a first-line mood stabilizer for the treatment of bipolar affective disorder
(BPAD). However, the efficacy of lithium varies widely, with a nonresponse rate of up to 30%…

Depressive symptom trajectories in late adolescence and early adulthood: A systematic review

KO Schubert, SR Clark, LK Van… - Australian & New …, 2017 - journals.sagepub.com
Objective: In adolescents and young adults, depressive symptoms are highly prevalent and
dynamic. For clinicians, it is difficult to determine whether a young person reporting …

Pharmacogenomics in the treatment of mood disorders: strategies and opportunities for personalized psychiatry

AT Amare, KO Schubert, BT Baune - EPMA journal, 2017 - Springer
Personalized medicine (personalized psychiatry in a specific setting) is a new model
towards individualized care, in which knowledge from genomics and other omic pillars (microbiome…

Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and …

KO Schubert, M Föcking, DR Cotter - Schizophrenia research, 2015 - Elsevier
… Author links open overlay panel Klaus Oliver Schubert a b , Melanie Föcking a , David R. …
Oliver Schubert with a Clinician Scientist Fellowship which included salary and funding for …

Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

AT Amare, KO Schubert, L Hou, SR Clark… - Molecular …, 2021 - nature.com
Lithium is a first-line medication for bipolar disorder (BD), but only one in three patients
respond optimally to the drug. Since evidence shows a strong clinical and genetic overlap …

Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients

KO Schubert, A Thalamuthu, AT Amare, J Frank… - Translational …, 2021 - nature.com
Lithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs
widely between individuals. The molecular mechanisms underlying treatment response …

Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder

AT Amare, A Thalamuthu, KO Schubert… - Molecular …, 2023 - nature.com
Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling
mental health disorder that affects about 1% of the population worldwide. Nevertheless, …

Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach

M Cearns, AT Amare, KO Schubert… - The British Journal of …, 2022 - cambridge.org
Background Response to lithium in patients with bipolar disorder is associated with clinical
and transdiagnostic genetic factors. The predictive combination of these variables might help …